Research Papers

25 of 735 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
A physiologically based pharmacokinetic model for [<sup>68</sup>Ga]Ga-(HA-)DOTATATE to predict whole-body distribution …
Siebinga H; de Wit-van der Veen BJ; Beijnen JH; Dorlo TPC; Huitema ADR; Hendrikx JJMA.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation.
Peters SMB; Mink MCT; Privé BM; de Bakker M; de Lange F; Muselaers CHJ; Mehra N; Witjes JA; Gotthardt M; Nagarajah J; Konijnenberg MW.
EJNMMI Res (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic rev…
de Mooij CM; Ploumen RAW; Nelemans PJ; Mottaghy FM; Smidt ML; van Nijnatten TJA.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Vessel-by-vessel analysis of lower extremity <sup>18</sup>F-NaF PET/CT imaging quantifies diabetes- and chronic kidney …
Chou TH; Rimmerman ET; Patel S; Wynveen MK; Eisert SN; Musini KN; Janse SA; Bobbey AJ; Sarac TP; Atway SA; Go MR; Stacy MR.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET.
Leung KH; Rowe SP; Leal JP; Ashrafinia S; Sadaghiani MS; Chung HW; Dalaie P; Tulbah R; Yin Y; VanDenBerg R; Werner RA; Pienta KJ; Gorin MA; Du Y; Pomper MG.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Relationships between uptake of [<sup>68</sup>Ga]Ga-DOTA-TATE and absorbed dose in [<sup>177</sup>Lu]Lu-DOTA-TATE thera…
Stenvall A; Gustafsson J; Larsson E; Roth D; Sundlöv A; Jönsson L; Hindorf C; Ohlsson T; Sjögreen Gleisner K.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Somatostatin receptor saturation after administration of high peptide amounts of [<sup>177</sup>Lu]Lu-HA-DOTATATE: when…
Siebinga H; Veerman CHAM; de Wit-van der Veen L; Stokkel MPM; Hendrikx JJMA; Aalbersberg EA.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Diagnostic models for fever of unknown origin based on <sup>18</sup>F-FDG PET/CT: a prospective study in China.
Chen J; Xing M; Xu D; Xie N; Zhang W; Ruan Q; Song J.
EJNMMI Res (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Radioimmunotherapy study of <sup>131</sup>I-labeled Atezolizumab in preclinical models of colorectal cancer.
Zhang L; Zhao S; Jiang H; Zhang R; Zhang M; Pan W; Sun Z; Wang D; Li J.
EJNMMI Res (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Evaluation of [<sup>68</sup> Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antige…
Koehler D; Sauer M; Karimzadeh A; Apostolova I; Klutmann S; Adam G; Knipper S; Maurer T; Berliner C.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Development and validation of <sup>68</sup>Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer.
Zang S; Ai S; Yang R; Zhang P; Wu W; Zhao Z; Ni Y; Zhang Q; Sun H; Guo H; Jia R; Wang F.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
First-in-human use of <sup>11</sup>C-CPPC with positron emission tomography for imaging the macrophage colony-stimulati…
Coughlin JM; Du Y; Lesniak WG; Harrington CK; Brosnan MK; O'Toole R; Zandi A; Sweeney SE; Abdallah R; Wu Y; Holt DP; Hall AW; Dannals RF; Solnes L; Horti AG; Pomper MG.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Development of a <sup>64</sup>Cu-labeled CD4<sup>+</sup> T cell targeting PET tracer: evaluation of CD4 specificity and…
Clausen AS; Christensen C; Christensen E; Cold S; Kristensen LK; Hansen AE; Kjaer A.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Effect of steroid treatment on the diagnostic yield of baseline <sup>18</sup>f-fluorodeoxyglucose positron emission tom…
Geiger KR; Pasvolsky O; Berger T; Raanani P; Shochat T; Gurion R; Anati T; Groshar D; Gafter-Gvili A; Bernstine H.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Short-time-window Patlak imaging using a population-based arterial input function and optimized Bayesian penalized like…
Tanaka T; Nakajo M; Kawakami H; Motomura E; Fujisaka T; Ojima S; Saigo Y; Yoshiura T.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
[<sup>18</sup>F]FE-PE2I PET is a feasible alternative to [<sup>123</sup>I]FP-CIT SPECT for dopamine transporter imaging…
Marner L; Korsholm K; Anderberg L; Lonsdale MN; Jensen MR; Brødsgaard E; Denholt CL; Gillings N; Law I; Friberg L.
EJNMMI Res (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[<sup>11</sup>C]Me-NB1.
Rischka L; Murgaš M; Pichler V; Vraka C; Rausch I; Winkler D; Nics L; Rasul S; Silberbauer LR; Reed MB; Godbersen GM; Unterholzner J; Handschuh P; Gryglewski G; Mindt T; Mitterhauser M; Hahn A; Ametamey SM; Wadsak W; Lanzenberger R; Hacker M.
EJNMMI Res (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
A pilot study of <sup>68</sup> Ga-PSMA-617 PET/CT imaging and <sup>177</sup>Lu-EB-PSMA-617 radioligand therapy in patie…
Wang G; Zhou M; Zang J; Jiang Y; Chen X; Zhu Z; Chen X.
EJNMMI Res (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent.
Fraser CR; Ajenjo J; Veal M; Dias GM; Chan C; O'Neill E; Destro G; Lau D; Pacelli A; Gouverneur V; Hueting R; Cornelissen B.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A guideline proposal for mice preparation and care in <sup>18</sup>F-FDG PET imaging.
Ribeiro FM; Correia PMM; Santos AC; Veloso JFCA.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Assessing the accuracy of [<sup>18</sup>F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate…
Ingvar J; Hvittfeldt E; Trägårdh E; Simoulis A; Bjartell A.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Changes of regional cerebral blood flow after deep brain stimulation in cervical dystonia.
Park S; Jeong H; Chung YA; Kang I; Kim S; Song IU; Huh R.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Combatting the effect of image reconstruction settings on lymphoma [<sup>18</sup>F]FDG PET metabolic tumor volume asses…
Ferrández MC; Eertink JJ; Golla SSV; Wiegers SE; Zwezerijnen GJC; Pieplenbosch S; Zijlstra JM; Boellaard R.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
[<sup>18</sup>F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer's disease pathology in …
Hsieh CJ; Hou C; Zhu Y; Lee JY; Kohli N; Gallagher E; Xu K; Lee H; Li S; McManus MJ; Mach RH.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-cent…
Donswijk ML; Wondergem M; de Wit-van der Veen L; Bruin NM; van Leeuwen PJ; van der Poel HG; Stokkel MPM; Vogel WV.
EJNMMI Res (Unknown)
Published: 2022
3/6 Transparent
Funding Declared